Condition
Allogeneic Stem Cell Transplantation clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Allogeneic Stem Cell Transplantation clinical trials that are recruiting, in United States. By phase: Phase 2 (3), Phase 3 (1). The most active sponsors are Center for International Blood and Marrow Transplant Research (2), University of California, Irvine (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1Country
Newest Allogeneic Stem Cell Transplantation clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| See if 18F-FAPI-74 PET/CT can better detect fibrosis in heart and lung disease | Phase 3 | Bethesda, Maryland | Recruiting | May 29, 2026 |
| Allogeneic stem cell transplant with low-dose post-transplant cyclophosphamide to prevent graft-versus-host disease. | Phase 2 | Hershey, Pennsylvania | Recruiting | Apr 13, 2025 |
| Evaluating CMV Prophylaxis After Stem Cell Transplant | Phase 2 | Orange, California | Recruiting | Jun 11, 2024 |
| Personalized conditioning regimen for stem cell transplantation | Phase 2 | Orange, California | Recruiting | Sep 8, 2023 |
| Research sample repository for blood and cellular therapies | — | New Brighton, Minnesota | Recruiting | Jun 9, 2021 |
| Comprehensive database for studying stem cell transplants and cellular therapies | — | Minneapolis, Minnesota and 1 other locations | Recruiting | Jul 20, 2010 |
All recruiting trials (6)
-
See if 18F-FAPI-74 PET/CT can better detect fibrosis in heart and lung disease
Researchers are testing a new PET/CT tracer, 18F-FAPI-74, to see if it can reveal early fibrotic changes in people with heart and lung diseases who are at risk for tissue scarring.
-
Allogeneic stem cell transplant with low-dose post-transplant cyclophosphamide to prevent graft-versus-host disease.
This study tests whether giving low-dose (25 mg/kg) cyclophosphamide on days +3 and +4 after allogeneic peripheral blood stem cell transplant can prevent GVHD in adults with blood cancers who receive reduced-intensity or non-myeloablative conditioning.
-
Evaluating CMV Prophylaxis After Stem Cell Transplant
This study is testing if a new test can help doctors decide how long to give a specific medicine to prevent a virus in patients who have had a stem cell transplant.
-
Personalized conditioning regimen for stem cell transplantation
This study is testing a personalized treatment plan for stem cell transplants in people with blood cancers to see if adjusting the doses of certain medications can improve their outcomes.
-
Research sample repository for blood and cellular therapies
This study is collecting blood samples to help researchers learn more about how to improve outcomes for people receiving blood and cell therapies.
-
Comprehensive database for studying stem cell transplants and cellular therapies
This study is creating a database to gather information on stem cell transplants and treatments to help improve recovery for patients and donors and make these therapies more accessible to everyone.
Related topics
Quick answers
How many Allogeneic Stem Cell Transplantation clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.